Anika Therapeutics, Inc.
$197.18M- Market cap
- $278.50M
- Debt
- +-$149.00K
- Cash
- −$81.17M
Capital structure 100% equity / -0% debt · EV / Revenue 1.75x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ANIK stock price at premium vs LEE $20.81 current versus $2.72 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at LEE's multiple
Implied fair value · at ANIK's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ANIK FY 2025 (ended Dec 31, 2025) · LEE FY 2025 (ended Sep 28, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 100% equity / -0% debt · EV / Revenue 1.75x
Capital structure 28% equity / 72% debt · EV / Revenue 1.11x
LEE carries the larger enterprise value at $626.71M against $197.18M; LEE trades on the lower EV / Revenue multiple (1.11x vs 1.75x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Anika Therapeutics, Inc. · implied price per share
At least 3 of the last 5 annual free-cash-flow observations must be positive.
LEE ENTERPRISES, INC · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
-0.00x
-10.52x
Net debt / EBITDA
Leverage against operating earnings
34.65x
-17.40x
Cash and equivalents
Liquid reserves on the balance sheet
$81.17M
$9.99M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ZIMMER BIOMET HOLDINGS, INC.
ANIK vs ZBH
STRYKER CORP
ANIK vs SYK
BECTON DICKINSON & CO
ANIK vs BDX
INTEGRA LIFESCIENCES HOLDINGS CORP
ANIK vs IART
NEW YORK TIMES CO
ANIK vs NYT
NEWS CORP
ANIK vs NWSA
Gannett Co., Inc.
ANIK vs GCI
Townsquare Media, Inc.
ANIK vs TSQ
SCHOLASTIC CORP
ANIK vs SCHL
-$149.00K
$455.47M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.